Phenformin
Phenformin is a biguanide class antidiabetic drug that was introduced in the 1950s for the treatment of type 2 diabetes. It was withdrawn from most markets in the late 1970s due to its association with a high risk of lactic acidosis.
History
Phenformin was developed in the 1950s and was widely used as an oral hypoglycemic agent. It was marketed under various brand names and was considered effective in lowering blood glucose levels in patients with type 2 diabetes. However, by the late 1970s, it became evident that phenformin was associated with a significant risk of lactic acidosis, a potentially fatal condition. As a result, it was withdrawn from the market in many countries.
Mechanism of Action
Phenformin works by decreasing hepatic gluconeogenesis and increasing peripheral glucose uptake. It also enhances the sensitivity of insulin receptors, thereby improving glucose utilization in the body. Unlike sulfonylureas, phenformin does not stimulate insulin secretion from the pancreas.
Side Effects
The most serious side effect of phenformin is lactic acidosis, which can be fatal. Other side effects include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. Due to its severe side effect profile, phenformin is no longer used in clinical practice.
Withdrawal from Market
The association of phenformin with lactic acidosis led to its withdrawal from the market in many countries. In the United States, the Food and Drug Administration (FDA) withdrew phenformin in 1977. Other countries followed suit, and it is now rarely used, having been replaced by other biguanides like metformin, which has a much lower risk of lactic acidosis.
Current Status
Phenformin is no longer widely available or used in clinical practice. However, it remains a subject of research, particularly in the context of its potential anticancer properties. Some studies have suggested that phenformin may have a role in inhibiting the growth of certain types of cancer cells, although this is still under investigation.
See Also
References
External Links
-
| Diabetes Drug Stub | |
|---|---|
| This article about a diabetes drug is a stub. You can help WikiMD by expanding it. | |
| Related topics | Diabetes mellitus · Insulin · Hypoglycemia · Hyperglycemia |
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD